These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 4583532)

  • 1. Biochemical evaluation of low dose of urokinase in acute myocardial infarction. A double-blind study.
    Gormsen J; Tidstrom B; Feddersen C; Ploug J
    Acta Med Scand; 1973; 194(3):191-8. PubMed ID: 4583532
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental and clinical studies on the thrombin-like enzyme from the venom of Bothrops atrox. On the primary structure of fragment E.
    Egberg N
    Acta Physiol Scand Suppl; 1973; 400():1-47. PubMed ID: 4599946
    [No Abstract]   [Full Text] [Related]  

  • 3. Free fatty acids (FFA)--blood clotting, fibrinolysis and platelet function.
    Korsan-Bengtsen K; Holm T
    Scand J Haematol; 1974; 13(1):64-71. PubMed ID: 4413510
    [No Abstract]   [Full Text] [Related]  

  • 4. Coagulolysis: mechanism of formation and lysis of dilute whole blood clots and application of this assay into study of certain hypercoagulable states.
    Taylor FB; Nilsson UR; Creech RH; Carroll ET; Beisswenger JG
    Ser Haematol; 1973; 6(4):528-48. PubMed ID: 4277409
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of coagulation and fibrinolysis after intravenous anisoylated plasminogen streptokinase activator complex or heparin in patients with acute myocardial infarction. A Belgian multicentre study.
    Renkin J; Beys CC; Lavenne-Pardonge E; Pintens H; Col J
    Drugs; 1987; 33 Suppl 3():253-60. PubMed ID: 3315603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urokinase "Green Cross", a new urokinase preparation. II. In vivo studies].
    Fischer M; Pilgerstorfer HW
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):142-9. PubMed ID: 4895445
    [No Abstract]   [Full Text] [Related]  

  • 7. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP; Hanssen M
    Drugs; 1987; 33 Suppl 3():247-52. PubMed ID: 2445540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of tenecteplase in acute myocardial infarction.
    Iavelov IS
    Kardiologiia; 2007; 47(1):37-46. PubMed ID: 17431964
    [No Abstract]   [Full Text] [Related]  

  • 9. [Systemic effects of thrombolytic therapy].
    Balduini CL; Gamba G; Bertolino G; Noris P; Previtali M; Ascari E
    Haematologica; 1991 Jun; 76 Suppl 3():281-90. PubMed ID: 1752524
    [No Abstract]   [Full Text] [Related]  

  • 10. [Venous thrombolysis with the recombinant human tissue-type plasminogen activator (rt-PA) during the first 3 hours following acute myocardial infarction. Controlled pilot study with placebo].
    Melandri G; Branzi A; Berardi C; Bruscoli F; Tartagni F; Binetti G; Galiè N; Magnani B; Gensini GF; Abbate R
    Cardiologia; 1987 Jul; 32(7):619-26. PubMed ID: 3319156
    [No Abstract]   [Full Text] [Related]  

  • 11. The effeCt of vitamin c supplements on serum cholesterol, coagulation, fibrinolysis and platelet adhesiveness.
    Crawford GP; Warlow CP; Bennett B; Dawson AA; Douglas AS; Kerridge DF; Ogston D
    Atherosclerosis; 1975; 21(3):451-4. PubMed ID: 807225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2 -Macroglobulin, 1 -antitrypsin, and antithrombin III in plasma and serum during fibrinolytic therapy with urokinase.
    Arnesen H; Fagerhol MK
    Scand J Clin Lab Invest; 1972 May; 29(3):259-63. PubMed ID: 4114014
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinolytic enhancement by stanozolol: a double blind trial.
    Davidson JF; Lochhead M; McDonald GA; McNicol GP
    Br J Haematol; 1972 May; 22(5):543-59. PubMed ID: 4555715
    [No Abstract]   [Full Text] [Related]  

  • 14. Oestrogenic treatment of prostatic cancer lowers the fibrinolytic activity in vein walls.
    Carlsson S; Astedt B
    Scand J Urol Nephrol; 1974; 8(3):169-72. PubMed ID: 4139751
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the thrombin clotting time. II. The influence of fibrin degradation products.
    Arnesen H
    Scand J Haematol; 1973; 10(4):291-7. PubMed ID: 4764611
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of a blood extract on plasma lipids, blood coagulation, fibrinolysis and platelet aggregation in experimental hypercholesterolemia of rabbits].
    Giarola P; Egge H; Gibelli A; Murawski U
    Arzneimittelforschung; 1974 Jun; 24(6):925-8. PubMed ID: 4408049
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots.
    Helle I
    Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525
    [No Abstract]   [Full Text] [Related]  

  • 18. Preliminary study of effect of aspirin and dipyridamole on platelet adhesiveness and fibrinolytic activity in acute myocardial infarction.
    Jhawar BK; Trivedi HH; Bhargava RK; Misra NP
    J Assoc Physicians India; 1978 Sep; 26(9):805-9. PubMed ID: 370078
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-benzal-butyric acid, a new anti-adhesive drug.
    Mannucci PM; Maggi CA; Gioventu M; Marchi E; Terruzzi AB
    Acta Univ Carol Med Monogr; 1972; 53():409-12. PubMed ID: 4670746
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulative and fibrinolytic studies on postmenopausal women treated with a new non-steroidal oestrogen.
    Kullander S; Svanberg L; Astedt B
    Acta Obstet Gynecol Scand; 1977; 56(4):371-4. PubMed ID: 74933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.